KIORA PHARMACEUTICALS INC awarded Lane Keith J. 55,000 derivative securities on 2026-09-17, leaving him with 55,000 derivative securities. For investors, the transaction establishes a new insider position and shows that the disclosed award represents 100.0% of his resulting derivative-securities holding in KIORA Pharmaceuticals.

Key Highlights

  • Lane Keith J. received 55,000 derivative securities from KIORA PHARMACEUTICALS INC on 17 September 2026.
  • The transaction left Lane Keith J. with 55,000 derivative securities.
  • The awarded securities represented about 100.0% of his resulting derivative-securities holding.

55,000 Derivative Securities Awarded

KIORA PHARMACEUTICALS INC (NASDAQ: KPRX) is a Pharmaceuticals: Major company. After the transaction, Lane Keith J.’s reported derivative-securities holding stood at 55,000. The transaction was recorded on 17 September 2026. The related disclosure identifies Lane Keith J. as an insider of KIORA Pharmaceuticals.

New Position Equals 100.0% of Resulting Holding

The reported award accounts for about 100.0% of Lane Keith J.’s resulting derivative-securities holding in KIORA Pharmaceuticals. The disclosure also classifies the event as a new insider position.